Tiaki Therapeutics

Tiaki has developed a platform in the field of systems biology that simulates the distinct transcriptomic pattern of neuroinflammation in individuals with dementia. This innovative system replicates the complex intercellular communication that is disrupted in CNS disorders, leading to a new era in the validation of therapeutic targets and the discovery of new drugs. Our unique method uncovers previously unidentified therapeutic targets and biomarkers based on the biological profile of patients with neuroinflammatory-related dementias. Our goal is to revolutionize the quality of life for patients and their families impacted by dementia through the provision of disease-altering treatments.